Terroir 2010 banner
IVES 9 IVES Conference Series 9 Comparative studies on the dynamics of fermentation of selected wine yeasts

Comparative studies on the dynamics of fermentation of selected wine yeasts

Abstract

Alcoholic fermentation is an anaerobic biochemical process of oxidation-reduction in which carbohydrates are metabolized by the action of yeast enzymes in major products (ethylalcohol and carbon dioxide) and minor products (superior alcohols, aldehydes, acetic acid, glycerol, volatile acids and others). Typical agents of the alcoholic fermentation are from Saccharomyces genus, by fermentation resulting concentrations in ethylic alcohol higher that 8 alcoholic degrees. In this paper it was studied the dynamics of fermentation of 3 strains of Saccharomyces ellipsoideus wine yeast and were observed parameters such as the accumulation of alcohol, the release of CO2, temperature, amount of oxygen released. It was found that alcoholic fermentation depends on medium factors but also on biotechnological qualities of yeasts selected for this purpose.

DOI:

Publication date: December 3, 2021

Issue: Terroir 2010

Type: Article

Authors

Ketney Otto,Tita Ovidiu, Oprean Letitia, Tita Mihaela, Gaspar Eniko, Lengyel Ecaterina

Lucian Blaga University
Faculty of Agricultural Sciences, Food Industry and Environmental Protection, Ioan Ratiu street no.7-9
Sibiu, Romania

Contact the author

Keywords

Alcoholic fermentation, Saccharomyces cerevisie var. ellipsoideus, yeast, fermenter

Tags

IVES Conference Series | Terroir 2010

Citation

Related articles…

Water status response of Vitis vinifera L. cv Cabernet-Sauvignon during the first years within the long-term VineyardFACE (Free Air Carbon dioxide Enrichment) study

Understanding the water-use responses of grapevines to increasing atmospheric carbon dioxide concentrations is mandatory when assessing the impact of climate change on viticulture as it is a critical part of the adaptation process.

Botrytis cinerea: Coconut or Catastrophe? Quantification of γ-Nonalactone in Botrytised and Non-Botrytised New Zealand Wines

g-Nonalactone has been identified as a significant contributor to the aroma profile of a range of wines and is associated with stonefruit and coconut descriptors.

Composition and biological potential of grape and wine phenolic compounds

Polyphenols are common in human diets, primarily in plant-derived food and beverages. They influence multiple sensory properties such as aroma, flavour, colour, and taste, such as astringency and bitterness [1]. The major phenolic compounds in grapes and wines are anthocyanins and tannins (proanthocyanidins or condensed tannins).

Correction de la teneur en alcool des vins par évaporation partielle sous vide en cours de fermentation alcoolique

Climate change has become a reality that is becoming more and more apparent every day, with changes in the physico-chemical composition of grapes and an increase in the alcohol content of finished wines. These higher alcoholic degrees are not without consequences for the success of alcoholic and malolactic fermentation. Correcting the alcohol content (-20% of the initial alcoholic strength) is also part of an approach designed to meet consumer expectations for healthier, lighter or lower-alcohol wines (9 to 13% vol.). Correcting the alcohol content of wines also rebalances the mouthfeel by reducing the alcohol’s burn.

Molecularly imprinted polymers: an innovative strategy for harvesting polyphenoles from grape seed extracts

Multiple sclerosis (MS) is a multifactorial autoimmune disease associating demyelination and axonal degeneration developing in young adults and affecting 2–3 million people worldwide. Plant polyphenols endowed with many therapeutic benefits associated with anti-inflammatory and antioxidant properties represent highly interesting new potential therapeutic strategies. We recently showed the safety and high efficiency of grape seed extract (GSE), a complex mixture of polyphenolics compounds comprising notably flavonoids and proanthocyanidins, in an experimental autoimmune encephalomyelitis (EAE) mouse model of MS.